&w=3840&q=100)
Mankind Pharma shares slide 3% as Q4 profit declines; details here
The Delhi-based pharma major's stock fell as much as 3.22 per cent during the day to ₹2,450 per share, the biggest intraday fall since May 2 this year. The stock pared losses to trade 2.1 per cent lower at ₹2,478 apiece, compared to a 1 per cent decline in Nifty 50 as of 9:32 AM.
Shares of the company extended losses to their fourth day and have fallen over 6 per cent from their recent highs of ₹2,610, which it hit earlier this month. The counter has fallen 14 per cent this year, compared to a 3.7 per cent advance in the benchmark Nifty 50. Mankind Pharma has a total market capitalisation of ₹1.01 trillion, according to BSE data.
Mankind Pharma Q4FY25 results
Mankind Pharma posted a 10 per cent fall in consolidated net profit Q4 FY25 at ₹424.65 crore from ₹476.59 crore in the same period last financial year. The pharma company's revenue from operations rose to ₹3,079 crore in Q4, a 27 per cent year-on-year (Y-o-Y) surge from ₹2,422 crore.
At the operating level, Mankind's earnings before interest, tax, depreciation, and amortisation (Ebitda) rose to ₹686 crore, with an Ebitda margin of 22.3 per cent in the March quarter. This compares to ₹589 crore and 24.3 per cent, respectively, in the same period last financial year.
The company reported that its domestic business revenues witnessed Y-o-Y growth of 18 per cent to ₹2,544 crore in the fourth quarter from ₹2,155 crore in Q4 FY24. It added that this growth was partially supported by continued outperformance in the chronic segment, at 1.3 times the Indian pharma market.
Mankind Pharma management commentary
Rajeev Juneja, vice-chairman (VC) and managing director (MD), said the company has achieved a healthy revenue growth in Q4. This was driven by strong growth in chronic therapies, recovery in the consumer segment and consolidation of Bharat Serums and Vaccines (BSV), he added.
'Recent key launches like Empagliflozin, Inclisiran and Vonoprazan were among the top five in their respective categories,' the company said in its investor presentation.
About Mankind Pharma
The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across as well as several consumer healthcare products. It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS vitamins /minerals/nutrients and respiratory.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
a minute ago
- Indian Express
After Germany & Dubai, women artisans take Phulkari to London
After showcasing their skills in Germany and Dubai, women from Bathinda are now taking Punjab's Phulkari to the global stage in London through HPCL-Mittal Energy Limited's (HMEL) initiative. HMEL, through its social development and livelihood promotion initiatives, is empowering rural women artisans who work with Phulkari in India and abroad. In the last week of July, at the Source Fashion Exhibition held at Olympia, London, the HMEL-supported Nabha Foundation collaborated with the Handloom Export Promotion Council (HEPC) under the India Pavilion and presented a display of Punjab's Phulkari. Over 200 handcrafted products, including 45 new designs, were showcased as per the demands of the international market. These included accessories, fabric swatches and traditional embroidered borders, said HMEL in a statement. 'The exhibition stall was visited by Nidhi Mani Tripathi, Minister (Economic), High Commission of India, London; Shreeranjani Kanagavel, First Secretary (Economic); and Rangaswamy from HEPC, who encouraged the artisans. We also visited premium stores such as Harrods to gain insights into global trends and product positioning,' said Manpreet Kaur, a Phulkari trainer and artisan, who was part of this tour. Nabha Foundation's Executive Director Shubhra Singh and Manpreet represented the women artisans. At the event, they connected with over 50 UK-based designers, boutique owners, exporters, and sourcing managers. Shirts and dresses by the Phulkari artisans, furnishing products caught the attention of interior designers and niche segments such as pet lifestyle brands. The visitors also got a chance to witness the intricate details and cultural heritage of Phulkari during the live embroidery demonstrations, the HMEL said. In addition, with HMEL's support, six women artisans participated in the Venix 2025 programme at IIM Bangalore from August 1 to August 3. They received valuable insights on new product ideas such as short kurtis, shrugs, and skirts, and also explored the area of online market and emerging market trends, said HMEL authorities. For the past two years, HMEL, in collaboration with Nabha Foundation, has been working to revive Phulkari through training camps, design innovation, market access, and participation in national and international exhibitions. These efforts have integrated Phulkari into modern fashion and lifestyle. Today, over 300 women from 22 villages are associated with this initiative, becoming self-reliant, and establishing their unique identity, the HMEL statement said.
Time of India
a minute ago
- Time of India
GIFT Nifty flat; here's the trading setup for today's session
Overall, analysts expect the market to remain range bound and domestic-facing themes likely to be in favour amidst caution over US tariffs and the outcome of the US-Russia peace talks scheduled for Friday. Indian equities saw gains as retail inflation hit an 8-year low, boosting domestic sentiment despite global geopolitical tensions. Analysts anticipate range-bound market activity, favoring domestic themes amid US tariff concerns and the upcoming US-Russia talks. US stocks rose, fueled by expectations of lower interest rates, while Asian stocks showed mixed performance. Tired of too many ads? Remove Ads STATE OF THE MARKETS Tech View: A decisive move above this level could trigger a rally towards 25,200 in the short term. On the lower side, support is placed at 24,337, below which the dynamics would once again turn in favor of the bears. India VIX: India VIX, which is a measure of the fear in the markets, fell 0.8% to settle at 12.14 levels. US stocks rise Asian stocks edge higher Tired of too many ads? Remove Ads Hang Seng futures rose 0.4% Japan's Topix fell 1.1% Australia's S&P/ASX 200 rose 0.6% Euro Stoxx 50 futures were little change Oil price rise Stocks in F&O ban today FII/DII action Rupee FII data Equities ended higher as India's retail inflation declined to an 8-year low in July, which improved domestic sentiments, even as the global geopolitical environment remains abuzz with action. Overall, analysts expect the market to remain range bound and domestic-facing themes likely to be in favour amidst caution over US tariffs and the outcome of the US-Russia peace talks scheduled for Friday. GIFT Nifty on the NSE IX traded higher by 3 points, or 0.01 per cent, at 24,692, signaling that Dalal Street was headed for a muted start on TuesdayU.S. stocks edged higher on Wednesday, extending a global rally fueled by expectations of lower interest rates. The S&P 500 gained 0.3% to notch another record high, the Dow Jones surged 463 points (1%), and the Nasdaq inched up 0.1% to a fresh stocks traded in a narrow range at Thursday's open, easing after three days of gains driven by bets on a Federal Reserve rate cut next prices edged higher on Thursday, regaining ground after a sell-off in the previous session, with the upcoming meeting between U.S. President Donald Trump and his Russian counterpart Vladimir Putin raising risk premiums in the crude futures were up 28 cents, or 0.43%, at $65.91 a barrel at 0057 GMT, while U.S. West Texas Intermediate crude futures rose 23 cents, or 0.37%, to $ HousingRBL BankPGELTitagarhSecurities in the ban period under the F&O segment include companies in which the security has crossed 95% of the market-wide position portfolio investors net sold shares worth Rs 3,644 crore on Wednesday. DIIs, meanwhile, were net buyers at Rs 5,624 rupee appreciated 20 paise to close at 87.43 against the US dollar on Wednesday, as a weak greenback and a positive momentum in domestic equity markets enthused position of FIIs in the futures market reduced from a net short of Rs 1.85 lakh crore on Tuesday to Rs 1.82 lakh crore on Wednesday.
The Hindu
a minute ago
- The Hindu
Lenovo charts hybrid course in a cloud market ruled by titans
In a global cloud infrastructure market valued at over $330 billion and dominated by a handful of hyperscalers, Lenovo is forging a distinct and strategic path. Rather than clashing head-on with giants like Amazon Web Services, Microsoft, and Google Cloud, the company's Infrastructure Solutions Group (ISG) is positioning itself as the indispensable foundational partner for a new era of hybrid, AI-driven computing, according to Amit Luthra, Managing Director for Lenovo ISG in India. 'Cloud is the form of the way IT is consumed,' Mr. Luthra said. 'Our strategy is to work with the complete ecosystem of the cloud—from hyperscalers and local service providers to large enterprises and SMBs.' This philosophy of collaboration over direct competition hinges on providing flexible, outcome-driven infrastructure. Mr. Luthra emphasised that the company has moved beyond simply selling hardware. The focus now is on delivering tangible results, a shift that requires a deep understanding of diverse customer needs and an open, interoperable architecture. 'We don't want to go back to our customers and say you have to let go of what you already have,' he explained, highlighting a core principle of avoiding proprietary lock-in. This allows organisations to build upon their existing IT investments, whether they are traditional on-premise systems or complex multi-cloud environments. This flexibility is particularly crucial when addressing the full spectrum of the market, from sprawling enterprises to agile small and medium-sized businesses (SMBs). Mr. Luthra pointed to a 'build vs. buy' dynamic, where many SMBs lack the resources for custom development. 'Most of the mid-market and SMB customers in India will want to buy IT — buy it like a package,' he noted. To serve this segment, Lenovo has cultivated a robust ecosystem of Independent Software Vendors (ISVs), enabling the delivery of pre-validated, turnkey solutions. 'We do have lot many solutions like these... to help them give a complete end-to-end packet solution,' Mr. Luthra added, citing examples like a 'ChatGPT in a box' for enterprises seeking a private, secure large language model. The catalyst for this market evolution, Mr. Luthra asserts, has been the explosion of artificial intelligence. While AI and analytics have been around for over a decade, the recent wave of generative models has fundamentally altered the landscape. 'GenAI took it to the mainstream. It became a boardroom imperative,' he stated. According to a global CIO survey conducted by Lenovo, India has emerged as a leader in AI adoption within the Asia-Pacific region. Indian organisations are leveraging the technology for both optimising existing processes — what Mr. Luthra calls improving 'business hygiene'—and driving disruptive innovation. Looking ahead, he believes the industry's focus is already shifting from the initial frenzy of training massive models to applying them for practical use. 'The big bet that I would have is on inferencing,' Mr. Luthra declared. 'The era of training and LLMs was a two years back story... while that is still on, inferencing is where the big bet is.' With this rapid technological advance, however, comes the critical responsibility of governance. Mr. Luthra said that security, privacy, and ethics are now central to every major technology discussion. 'Responsible AI is a very, very big discussion point in deploying most of these solutions,' he said. 'People want to talk about security, people want to talk about ethics. This is where IT makes the excitement in the board real.'
